Related references
Note: Only part of the references are listed.Mutational landscape of K-Ras substitutions at 12th position-a systematic molecular dynamics approach
Udhaya S. Kumar et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Whole-exome sequencing analysis of NSCLC reveals the pathogenic missense variants from cancer-associated genes
S. Udhaya Kumar et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2022)
Computational investigation to identify potent inhibitors of the GTPase-Kirsten RAt sarcoma virus (K-Ras) mutants G12C and G12D
S. Udhaya Kumar et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2021)
Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial
Kevin Kalinsky et al.
JAMA ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Characteristics and Outcome of AKT1E17K_Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry
Lillian M. Smyth et al.
CANCER DISCOVERY (2020)
Autophagy in Human Diseases
Noboru Mizushima et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Common cancer mutations R175H and R273H drive the p53 DNA-binding domain towards aggregation-prone conformations
Le Li et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2020)
A computational approach for investigating the mutational landscape of RAC-alpha serine/threonine-protein kinase (AKT1) and screening inhibitors against the oncogenic E17K mutation causing breast cancer
D. Thirumal Kumar et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2019)
Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis
Yan Stein et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Exploration of intermediate-sized INDELs by next-generation multigene panel testing in Han Chinese patients with breast cancer
Chihiro Hata et al.
HUMAN GENOME VARIATION (2019)
From mutational inactivation to aberrant gain-of-function: Unraveling the structural basis of mutant p53 oncogenic transition
Fisayo A. Olotu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Ensembl 2018
Daniel R. Zerbino et al.
NUCLEIC ACIDS RESEARCH (2018)
The Reactome Pathway Knowledgebase
Antonio Fabregat et al.
NUCLEIC ACIDS RESEARCH (2018)
The role of TGF-beta/SMAD4 signaling in cancer
Ming Zhao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
GeneMANIA update 2018
Max Franz et al.
NUCLEIC ACIDS RESEARCH (2018)
IMSindel: An accurate intermediate-size indel detection tool incorporating de novo assembly and gapped global-local alignment with split read analysis
Daichi Shigemizu et al.
SCIENTIFIC REPORTS (2018)
TGF-β receptors: In and beyond TGF-β signaling
Alexandra Vander Ark et al.
CELLULAR SIGNALLING (2018)
AKT Inhibition in Solid Tumors With AKT1 Mutations
David M. Hyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence
Uemmueguelsuem Yesiloez et al.
NEURO-ONCOLOGY (2017)
The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance
Sunjida Ahmed et al.
JOURNAL OF CLINICAL MEDICINE (2017)
SIFT missense predictions for genomes
Robert Vaser et al.
NATURE PROTOCOLS (2016)
AKT1E17K mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection
Marion Rudolph et al.
BMC CANCER (2016)
TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
Liacine Bouaoun et al.
HUMAN MUTATION (2016)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
Mechanisms underlying structural variant formation in genomic disorders
Claudia M. B. Carvalho et al.
NATURE REVIEWS GENETICS (2016)
TGF-β Signaling from Receptors to Smads
Akiko Hata et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
The Ensembl Variant Effect Predictor
William McLaren et al.
GENOME BIOLOGY (2016)
Reactivating mutant p53 using small molecules as zinc metallochaperones: awakening a sleeping giant in cancer
Adam R. Blanden et al.
DRUG DISCOVERY TODAY (2015)
A global reference for human genetic variation
David M. Altshuler et al.
NATURE (2015)
Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals
Masao Nagasaki et al.
NATURE COMMUNICATIONS (2015)
Mutant AKT1-E17K is oncogenic in lung epithelial cells
Carmela De Marco et al.
Oncotarget (2015)
Modelling Circulating Tumour Cells for Personalised Survival Prediction in Metastatic Breast Cancer
Gianluca Ascolani et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Synthetic Metallochaperone ZMC1 Rescues Mutant p53 Conformation by Transporting Zinc into Cells as an Ionophore
Adam R. Blanden et al.
MOLECULAR PHARMACOLOGY (2015)
Single nucleotide variations: Biological impact and theoretical interpretation
Panagiotis Katsonis et al.
PROTEIN SCIENCE (2014)
PredictSNP: Robust and Accurate Consensus Classifier for Prediction of Disease-Related Mutations
Jaroslav Bendl et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data
Gabriela Bindea et al.
BIOINFORMATICS (2013)
The p53-Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevity
Vinod Pant et al.
GENES & DEVELOPMENT (2013)
The UCSC Genome Browser database: extensions and updates 2013
Laurence R. Meyer et al.
NUCLEIC ACIDS RESEARCH (2013)
Cancer Associated E17K Mutation Causes Rapid Conformational Drift in AKT1 Pleckstrin Homology (PH) Domain
Ambuj Kumar et al.
PLOS ONE (2013)
The UK Adult Twin Registry (TwinsUK Resource)
Alireza Moayyeri et al.
TWIN RESEARCH AND HUMAN GENETICS (2013)
Role of PI3K-AKT-mTOR and Wnt signaling pathways in transition of G1-S phase of cell cycle in cancer cells
Lakshmipathi Vadlakondalf et al.
FRONTIERS IN ONCOLOGY (2013)
Two sides of the story? Smad4 loss in pancreatic cancer versus head-and-neck cancer
Stephen P. Malkoski et al.
FEBS LETTERS (2012)
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy
Jacqueline A. Shaw et al.
GENOME RESEARCH (2012)
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens et al.
NATURE (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets
Andreas Wilm et al.
NUCLEIC ACIDS RESEARCH (2012)
Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing
Rebecca J. Leary et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Using bioinformatics to predict the functional impact of SNVs
Melissa S. Cline et al.
BIOINFORMATICS (2011)
Definition and testing of the GROMOS force-field versions 54A7 and 54B7
Nathan Schmid et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2011)
CD47 regulates the TGF-β signaling pathway in osteoblasts and is distributed in Meckel's cartilage
Koichi Shimada et al.
Journal of Oral Science (2011)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
Global Patterns of Cancer Incidence and Mortality Rates and Trends
Ahmedin Jemal et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Cell-free DNA in the blood as a solid tumor biomarker-A critical appraisal of the literature
Klaus Jung et al.
CLINICA CHIMICA ACTA (2010)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
APPLICATIONS OF NEXT-GENERATION SEQUENCING Sequencing technologies - the next generation
Michael L. Metzker
NATURE REVIEWS GENETICS (2010)
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
Gabriela Bindea et al.
BIOINFORMATICS (2009)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Molecular Mechanism of an Oncogenic Mutation That Alters Membrane Targeting: Glu17Lys Modifies the PIP Lipid Specificity of the AKT1 PH Domain
Kyle E. Landgraf et al.
BIOCHEMISTRY (2008)
Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias
M. S. Kim et al.
BRITISH JOURNAL OF CANCER (2008)
Integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer
Katherine Stemke-Hale et al.
CANCER RESEARCH (2008)
AKT1E17K in human solid tumours
F. E. Bleeker et al.
ONCOGENE (2008)
GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function
Sara Mostafavi et al.
GENOME BIOLOGY (2008)
Mutant p53 attenuates the SMAD-dependent transforming growth factor β1 (TGF-β1) signaling pathway by repressing the expression of TGF-β receptor type II
Eyal Kalo et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer
John D. Carpten et al.
NATURE (2007)
Integration of TGF-β and Ras/MAPK signaling through p53 phosphorylation
Michelangelo Cordenonsi et al.
SCIENCE (2007)
Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information
E. Capriotti et al.
BIOINFORMATICS (2006)
Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains
Hwee Ching Ang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences
Weizhong Li et al.
BIOINFORMATICS (2006)
Autophagy signaling and the cogwheels of cancer
Joelle Botti et al.
AUTOPHAGY (2006)
Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral
SV Tavtigian et al.
JOURNAL OF MEDICAL GENETICS (2006)
Prediction of protein stability changes for single-site mutations using support vector machines
JL Cheng et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
Smad4-expression is decreased in breast cancer tissues: a retrospective study
CH Stuelten et al.
BMC CANCER (2006)
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway
YB Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression
DC Fingar et al.
ONCOGENE (2004)
Coregulator function: A key to understanding tissue specificity of selective receptor modulators
CL Smith et al.
ENDOCRINE REVIEWS (2004)
Comparison of site-specific rate-inference methods for protein sequences: Empirical Bayesian methods are superior
I Mayrose et al.
MOLECULAR BIOLOGY AND EVOLUTION (2004)
Smad4 as a transcription corepressor for estrogen receptor α
LY Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Predicting changes in the stability of proteins and protein complexes: A study of more than 1000 mutations
R Guerois et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
VJN Bykov et al.
NATURE MEDICINE (2002)
TP53: a key gene in human cancer
DP Guimaraes et al.
BIOCHIMIE (2002)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Signaling inputs converge on nuclear effecters in TGF-β signaling
P ten Dijke et al.
TRENDS IN BIOCHEMICAL SCIENCES (2000)
Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells
A Petiot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
